Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125027292 | 12502729 | 2 | F | 20160604 | 20160827 | 20160628 | 20160902 | EXP | JP-ROCHE-1782415 | ROCHE | 29.00 | YR | F | Y | 44.00000 | KG | 20160902 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125027292 | 12502729 | 1 | PS | COPEGUS | RIBAVIRIN | 1 | Oral | DOSAGE IS UNCERTAIN.?DISCONTINUED AT A DOSE OF AT 200 MG | 21511 | TABLET | BID | ||||||||
125027292 | 12502729 | 2 | SS | SOVALDI | SOFOSBUVIR | 1 | Oral | FRACTIONATION DOSE UNCERTAIN FREQUENCY AND DOSE INTERVAL UNCERTAINTY | 0 | 400 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125027292 | 12502729 | 1 | Chronic hepatitis C |
125027292 | 12502729 | 2 | Chronic hepatitis C |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125027292 | 12502729 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125027292 | 12502729 | Abortion spontaneous | |
125027292 | 12502729 | Maternal exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125027292 | 12502729 | 1 | 20160517 | 20160530 | 0 | |
125027292 | 12502729 | 2 | 20160517 | 20160530 | 0 |